Elimination of HCV as a public health concern among people who inject drugs by 2030 - What will it take to get there? - Articles - Infectiology · Anesthesiology · Pain

Viral Infections, Non-HIV

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study

Clin Infect Dis.

Artenie AA, Cunningham EB, Dore GJ, Conway B, Dalgard O, Powis J, Bruggmann P, Hellard M, Cooper C, Read P, Feld JJ, Hajarizadeh B, Amin J, Lacombe K, Stedman C, Litwin AH, Marks P, Matthews GV, Quiene S, Erratt A, Bruneau J, Grebely J

doi: 10.1093/cid/ciz633.

Viral Infections, Non-HIV

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030

Swiss Med Wkly.

Bruggmann P, Blach S, Deltenre P, Fehr J, Kouyos R, Lavanchy D, Müllhaupt B, Rauch A, Razavi H, Schmid P, Semela D, Stoeckle M, Negro F

doi: 10.4414/smw.2017.14543.

HIV / AIDSViral Infections, Non-HIV

Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study

Lancet Infect Dis.

Zelenev A, Li J, Mazhnaya A, Basu S, Altice FL

doi: 10.1016/

HIV / AIDS

HIV outbreaks among people who inject drugs in Europe, North America, and Israel

Lancet HIV.

Des Jarlais DC, Sypsa V, Feelemyer J, Abagiu AO, Arendt V, Broz D, Chemtob D, Seguin-Devaux C, Duwve JM, Fitzgerald M, Goldberg DJ, Hatzakis A, Jipa RE, Katchman E, Keenan E, Khan I, Konrad S, McAuley A, Skinner S, Wiessing L

doi: 10.1016/S2352-3018(20)30082-5.

HIV / AIDSViral Infections, Non-HIV

Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis

J Infect Dis.

Martin NK, Jansen K, An der Heiden M, Boesecke C, Boyd A, Schewe K, Baumgarten A, Lutz T, Christensen S, Thielen A, Mauss S, Rockstroh JK, Skaathun B, Ingiliz P

doi: 10.1093/infdis/jiz367.

HIV / AIDS

Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018

Antivir Ther.

Kusejko K, Marzel A, Nguyen H, Chaudron SE, Bachmann N, Weber R, Bruggmann P, Roth JA, Bernasconi E, Calmy A, Cavassini M, Bregenzer A, Böni J, Yerly S, Klimkait T, Perreau M, Walti LN, Günthard HF, Kouyos RD, Swiss HIV Cohort Study.

doi: 10.3851/IMP3347.

HIV / AIDSViral Infections, Non-HIV

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs

Ann Intern Med.

Kandathil AJ, Breitwieser FP, Sachithanandham J, Robinson M, Mehta SH, Timp W, Salzberg SL, Thomas DL, Balagopal A

doi: 10.7326/M17-0085.

Bacterial InfectionsHIV / AIDS

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

Clin Infect Dis.

Campbell JR, Al-Jahdali H, Bah B, Belo M, Cook VJ, Long R, Schwartzman K, Trajman A, Menzies D

doi: 10.1093/cid/ciaa1169.

HIV / AIDS

The WHO public health approach to HIV treatment and care: looking back and looking ahead

Lancet Infect Dis.

Ford N, Ball A, Baggaley R, Vitoria M, Low-Beer D, Penazzato M, Vojnov L, Bertagnolio S, Habiyambere V, Doherty M, Hirnschall G

doi: 10.1016/S1473-3099

Related content

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study

Hepatitis C virus dynamics among intravenous drug users suggest that an annual treatment uptake above 10% would eliminate the disease by 2030

Hepatitis C virus treatment as prevention in an extended network of people who inject drugs in the USA: a modelling study

HIV outbreaks among people who inject drugs in Europe, North America, and Israel

Can HCV be eliminated among HIV-positive men who have sex with men in Berlin? A modeling analysis

Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018

Presence of Human Hepegivirus-1 in a Cohort of People Who Inject Drugs

Safety and Efficacy of Rifampin or Isoniazid Among People with Mycobacterium tuberculosis Infection and Living with HIV or Other Health Conditions: Post-Hoc Analysis of Two Randomized Trials

The WHO public health approach to HIV treatment and care: looking back and looking ahead